Nuclear Medicine Is Big Pharma' s New Target in Cancer Race (1) As pharma giants spend billions on acquisitions of startups developing new ways to harness radiation in the fight against cancer, the chief executive offic... A Fuhong - 《Bloomberg Law Ip Law News》 被引量: 0发表: 2024年...
BioSpectrum is an integrated B2B media platform for the healthcare and bioscience industry in India and Asia.
25 February, 2025 | Tuesday | News Novotech inks MoU with Wonju Severance Christian Hospital to drive clinical research excellence in Korea Novotech, a global full-service clinical Contract Research Organisation (CRO) that partners with biotech and s 19 February, 2025 | Wednesday | NewsInside...
Pharmacists need an opportunity to update the medicine in stock from warehouses. Courier app The courier app has to be straightforward but functional. There are several required features: Registration and login. Couriers need to sign up to use the app. It’s better to add sign in options ...
business development, data analytics, and many more. ThePharmaconsultants work with organizations of all sizes including academic institutes, start-up companies, and established organizations. The services aim to increase the patient’s knowledge of theirmedicationand improve their adherence to the regimen...
Amidst global efforts to revolutionize healthcare, startups in the medical and pharma sectors are driving transformative innovations. They are developing cutting-edge solutions in diagnostics, therapeutics, and biotechnology, including AI-powered tools, gene ...
Areic India Pharma is Top Pharmaceutical manufacturer in India offering excellence in discovery, development. Pharmaceutical Manufacturing Company in India.
obesity by 2030. Obesity has become big pharma's latest obsession, with significant interest and investment in this space. Both big pharma and small startups are jumping into the race, investing billions in combating obesity. Let's delve deeper into what's driving the appetite for obesity ...
JB Pharma reports revenue growth of 14% in Q3 FY25; Net profit up by 22% Philogen completes patient enrollment of Phase III FIBROSARC trial in Soft Tissue Sarcoma Hikal Q3 FY25 consolidated revenue recorded at Rs. 448 Cr India reaffirms commitment to global pharmaceutical standardization and ...
India, Qatar to focus on sustainable partnership: Piyush Goyal India’s first semiconductor chip unit to start production this year Reliance arm to build 10 GWh Advanced Chemistry Cell capacity under PLI scheme India’s merchandise trade deficit shoots up to $243 billion in April-January 2024-25...